477 posters, 14 topics, 2,052 authors, 1,056 institutions

The Joint EBJIS-MSIS 2026 Conference

17 - 19 September, 2026 | Porto, Portugal

Topics

Showing 477 results.

$Thumbnail for First-in-human intra-articular endolysin* therapy for treatment-refractory prosthetic joint infection: expanded-access clinical experience$

PP24

First-in-human intra-articular endolysin* therapy for treatment-refractory prosthetic joint infection: expanded-access clinical experience

Julian Maamari, Assaf Raz, Bryan Li, Mark Spangehl, Brennan Boettcher, Jacob Sellon, Raymond Schuch, Gina Suh

Mayo Clinic, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochster, United States, Precisio Biotix Therapeutics, Dover, United States, Department of Orthopaedic Surgery...

Poster Presenter: Gina Suh

Thumbnail for Rifampicin-resistant Staphylococcus epidermidis implant-associated bone and joint infections: high rate of multidrug-resistance and treatment failure
� a retrospective cohort study

PP25

Rifampicin-resistant Staphylococcus epidermidis implant-associated bone and joint infections: high rate of multidrug-resistance and treatment failure � a retrospective cohort study

Michaela Schumacher, Mario Morgenstern, Martin Clauss, Peter M. Keller, Nina Khanna, Richard A. Kühl

University Hospital Basel, Division of Infectious Diseases, University of Basel and University Hospital Basel, Basel, Switzerland, Center for Musculoskeletal Infections (ZMSI), Department of Orthopaedic and Tra...

The Joint EBJIS-MSIS 2026 Conference

Topics

First-in-human intra-articular endolysin* therapy for treatment-refractory prosthetic joint infection: expanded-access clinical experience

Rifampicin-resistant Staphylococcus epidermidis implant-associated bone and joint infections: high rate of multidrug-resistance and treatment failure � a retrospective cohort study

From Probability to Action: Patient-Specific Thresholds for Diagnosing Chronic Prosthetic Joint Infection

Risk Factors and Clinical Impact of Multidrug-Resistant Pathogens in Fracture-Related Infection

Microbiological Profile and Pathogen Turnover Across Sequential Debridement in Orthopaedic Infection

Microbial causes of prosthetic joint infections at a Swedish secondary hospital 2010 to 2022

The Result of Standardized �No Touch Sampling Technique� Combine with BCB for Bone and Soft Tissue Infection

The Utility of the Minimum Biofilm Eradication Concentration (MBEC) for Predicting Prosthetic Joint Infection Treatment Outcome

How Bioactive Glass S53P4 Kills bacteria

Comparing microbes detected by culture, next-generation sequencing, multiplex PCR, and antigen immunoassay in matched synovial fluid testing

Arthroscopic Versus Open Irrigation and Debridement for Acute Shoulder Septic Arthritis: A Propensity-Matched Retrospective Cohort Study

A multi-timepoint evaluation of health-related quality of life in bone and joint infection using the EQ-5D-5L instrument